In contrast, our findings are based on the transcriptomic analyses of IDH-mutant gliomas against a set of experimentally proven markers and fate determining regulators, and we made no alterations to the signature gene sets derived from purified glial cell populations. This evidence concerns the gene IDH1 and glioma.